Skip to main content

Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice

Publication ,  Journal Article
Tolonen, AM; Magga, J; Szabó, Z; Viitala, P; Gao, E; Moilanen, AM; Ohukainen, P; Vainio, L; Koch, WJ; Kerkelä, R; Ruskoaho, H; Serpi, R
Published in: Pharmacology Research and Perspectives
August 1, 2014

The members of lethal-7 (Let-7) microRNA (miRNA) family are involved in regulation of cell differentiation and reprogramming of somatic cells into induced pluripotent stem cells. However, their function in the heart is not known. In this study, we examined the effect of inhibiting the function of Let-7c miRNA on the progression of postinfarction left ventricular (LV) remodeling in mice. Myocardial infarction was induced with permanent ligation of left anterior descending coronary artery with a 4-week follow-up period. Let-7c miRNA was inhibited with a specific antagomir administered intravenously. The inhibition of Let-7c miRNA downregulated the levels of mature Let-7c miRNA and its other closely related members of Let-7 family in the heart and resulted in increased expression of pluripotency-associated genes Oct4 and Sox2 in cardiac fibroblasts in vitro and in adult mouse heart in vivo. Importantly, Let-7c inhibitor prevented the deterioration of cardiac function postinfarction, as demonstrated by preserved LV ejection fraction and elevated cardiac output. Improvement in cardiac function by Let-7c inhibitor postinfarction was associated with decreased apoptosis, reduced fibrosis, and reduction in the number of discoidin domain receptor 2–positive fibroblasts, while the number of c-kit+ cardiac stem cells and Ki-67+ proliferating cells remained unaltered. In conclusion, inhibition of Let-7 miRNA may be beneficial for the prevention of postinfarction LV remodeling and progression of heart failure.

Duke Scholars

Published In

Pharmacology Research and Perspectives

DOI

EISSN

2052-1707

Publication Date

August 1, 2014

Volume

2

Issue

4

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 0304 Medicinal and Biomolecular Chemistry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tolonen, A. M., Magga, J., Szabó, Z., Viitala, P., Gao, E., Moilanen, A. M., … Serpi, R. (2014). Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacology Research and Perspectives, 2(4). https://doi.org/10.1002/prp2.56
Tolonen, A. M., J. Magga, Z. Szabó, P. Viitala, E. Gao, A. M. Moilanen, P. Ohukainen, et al. “Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice.” Pharmacology Research and Perspectives 2, no. 4 (August 1, 2014). https://doi.org/10.1002/prp2.56.
Tolonen AM, Magga J, Szabó Z, Viitala P, Gao E, Moilanen AM, et al. Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacology Research and Perspectives. 2014 Aug 1;2(4).
Tolonen, A. M., et al. “Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice.” Pharmacology Research and Perspectives, vol. 2, no. 4, Aug. 2014. Scopus, doi:10.1002/prp2.56.
Tolonen AM, Magga J, Szabó Z, Viitala P, Gao E, Moilanen AM, Ohukainen P, Vainio L, Koch WJ, Kerkelä R, Ruskoaho H, Serpi R. Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacology Research and Perspectives. 2014 Aug 1;2(4).

Published In

Pharmacology Research and Perspectives

DOI

EISSN

2052-1707

Publication Date

August 1, 2014

Volume

2

Issue

4

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 0304 Medicinal and Biomolecular Chemistry